Hospitals Urged to Treat Drug Diversion Prevention as a Strategic Investment

• 

  Drug diversion has consequences that extend beyond pharmacy operations.

• 

  Legal, compliance, nursing, risk management, human resources and executive teams may be involved in lengthy investigations and remediation.

• 

  The article says hospitals should treat diversion prevention as a strategic investment rather than a compliance expense.

• 

  It cites increasing regulatory scrutiny and financial pressures facing health systems.

Who

Health systems and the teams involved in drug diversion investigations.

What

The article argues that preventing drug diversion should be treated as a strategic investment, not a compliance expense.

When

Published October 12, 2026.

Where

Not stated.

Why

Drug diversion can lead to lengthy investigations and remediation, while health systems face increased regulatory scrutiny and financial pressures.

This story does not have two clearly opposing sides.

No direct quotes in the coverage so far.

This story does not have a timeline yet.